Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AMARIN CORP PLC\UKAMRN · Entity 5970 | EVP, Chief Scientific Officer | July 01, 2026 | July 15, 2026 |
| Viracta Therapeutics, Inc.SNSS · Entity 85616 | Director | June 30, 2020 | July 01, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AMARIN CORP PLC\UK
Report date July 01, 2026 · Filed July 15, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| American Depositary SharesSEC Table I · non-derivative | Direct | 42,680 |
Last balance in matching sequence
After 2026-07-01 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2026-07-01 · Exercise / conversion · Acquired 3,688 · Balance 44,567 F1: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. F2: On January 10, 2025, the Reporting Person was granted 7,376 Restricted Stock Units ("RSUs") under the Amarin Corporation plc 2020 Stock Incentive Plan (the "Plan"). The shares subject to this grant shall vest over eighteen months, with 50% to vest on January 2, 2026 and the remaining balance to vest on July 1, 2026. F3: Not applicable. Row 2 · 2026-07-01 · Tax withholding · Disposed 1,887 · Balance 42,680 F1: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. F4: Represents withholding by the Issuer of shares in respect of tax liability incident to the vesting of a security issued in accordance with Rule 16b-3, and not a market sale of securities. |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2026-07-01 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-07-01 · Grant · Acquired 3,688 · Balance 0 F5: Each RSU represents a contingent right to receive twenty Ordinary Shares or cash in lieu thereof at the Issuer's discretion. F1: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change. F2: On January 10, 2025, the Reporting Person was granted 7,376 Restricted Stock Units ("RSUs") under the Amarin Corporation plc 2020 Stock Incentive Plan (the "Plan"). The shares subject to this grant shall vest over eighteen months, with 50% to vest on January 2, 2026 and the remaining balance to vest on July 1, 2026. F3: Not applicable. |
Filing footnotes · ownership attribution and instrument terms
F1: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change.
F2: On January 10, 2025, the Reporting Person was granted 7,376 Restricted Stock Units ("RSUs") under the Amarin Corporation plc 2020 Stock Incentive Plan (the "Plan"). The shares subject to this grant shall vest over eighteen months, with 50% to vest on January 2, 2026 and the remaining balance to vest on July 1, 2026.
F3: Not applicable.
F4: Represents withholding by the Issuer of shares in respect of tax liability incident to the vesting of a security issued in accordance with Rule 16b-3, and not a market sale of securities.
F5: Each RSU represents a contingent right to receive twenty Ordinary Shares or cash in lieu thereof at the Issuer's discretion.
Viracta Therapeutics, Inc.
Report date June 30, 2020 · Filed July 01, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.26 · Expires 2030-06-30 | Direct | 60,000 |
Reported balance
After 2020-06-30 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2020-06-30 · Grant · Acquired 60,000 · Balance 60,000 F1: The option shall vest and become exercisable in twelve (12) equal monthly installments over a one (1) year period following the date of grant subject to the Reporting Person's continuous service on the Board through each such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The option shall vest and become exercisable in twelve (12) equal monthly installments over a one (1) year period following the date of grant subject to the Reporting Person's continuous service on the Board through each such vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 25, 2018 Filed Sep 27, 2018 00:52 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionOrdinary Shares | 200,000 | $8.77 | $1,754,000.00 |
DisclosureSEC source: 0001209191-18-052388 · doc4.xml · nonDerivative · entry 11 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 541,297 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| September 24, 2018 Filed Sep 27, 2018 00:52 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $8.77 | $0.00 |
DisclosureSEC source: 0001209191-18-052388 · doc4.xml · derivative · entry 20 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500,000 Underlying: Ordinary Shares · 100,000 shares Expires 2022-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: The option granted to the Reporting Person is fully vested as of the date hereof. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| September 24, 2018 Filed Sep 27, 2018 00:52 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionStock Option (Right to Buy) · Derivative | 33,750 | $0.00 Strike: $8.10 | $0.00 |
DisclosureSEC source: 0001209191-18-052388 · doc4.xml · derivative · entry 19 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 33,750 shares Expires 2023-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: The option granted to the Reporting Person is fully vested as of the date hereof. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| September 24, 2018 Filed Sep 27, 2018 00:52 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionStock Option (Right to Buy) · Derivative | 52,147 | $0.00 Strike: $2.95 | $0.00 |
DisclosureSEC source: 0001209191-18-052388 · doc4.xml · derivative · entry 18 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,853 Underlying: Ordinary Shares · 52,147 shares Expires 2027-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: On February 1, 2017, the Reporting Person was granted an option to purchase 133,000 Ordinary Shares under the Plan. The shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month that began on February 28, 2017. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| September 24, 2018 Filed Sep 27, 2018 00:52 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionStock Option (Right to Buy) · Derivative | 142,500 | $0.00 Strike: $2.50 | $0.00 |
DisclosureSEC source: 0001209191-18-052388 · doc4.xml · derivative · entry 17 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,500 Underlying: Ordinary Shares · 142,500 shares Expires 2025-07-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: On July 6, 2015, the Reporting Person was granted an option to purchase 180,000 Ordinary Shares under the Plan. The vesting of the shares is subject to certain performance milestone that was previously achieved. The shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month that began on July 31, 2015. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| September 24, 2018 Filed Sep 27, 2018 00:52 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionStock Option (Right to Buy) · Derivative | 112,500 | $0.00 Strike: $2.50 | $0.00 |
DisclosureSEC source: 0001209191-18-052388 · doc4.xml · derivative · entry 16 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,500 Underlying: Ordinary Shares · 112,500 shares Expires 2025-07-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: On July 6, 2015, the Reporting Person was granted an option to purchase 180,000 Ordinary Shares under the Plan. The vesting of the shares is subject to certain performance milestone that was previously achieved. The shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month that began on July 31, 2015. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| September 24, 2018 Filed Sep 27, 2018 00:52 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionStock Option (Right to Buy) · Derivative | 158,334 | $0.00 Strike: $2.50 | $0.00 |
DisclosureSEC source: 0001209191-18-052388 · doc4.xml · derivative · entry 15 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,666 Underlying: Ordinary Shares · 158,334 shares Expires 2025-07-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: On July 6, 2015, the Reporting Person was granted an option to purchase 200,000 Ordinary Shares under the Plan. The shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month that began on July 31, 2015. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| September 24, 2018 Filed Sep 27, 2018 00:52 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionStock Option (Right to Buy) · Derivative | 20,834 | $0.00 Strike: $1.40 | $0.00 |
DisclosureSEC source: 0001209191-18-052388 · doc4.xml · derivative · entry 14 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,270 Underlying: Ordinary Shares · 20,834 shares Expires 2026-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: On February 1, 2016, the Reporting Person was granted an option to purchase 125,000 Ordinary Shares under the Amarin Corporation plc 2011 Stock Incentive Plan (the "Plan"). The shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month that began on February 29, 2016. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| September 24, 2018 Filed Sep 27, 2018 00:52 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | SaleOrdinary Shares | 100,000 | $12.00 | $1,200,000.00 |
DisclosureSEC source: 0001209191-18-052388 · doc4.xml · nonDerivative · entry 10 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 341,297 F1 · security: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| September 24, 2018 Filed Sep 27, 2018 00:52 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | SaleOrdinary Shares | 49,450 | $10.94 | $540,869.27 |
DisclosureSEC source: 0001209191-18-052388 · doc4.xml · nonDerivative · entry 9 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 441,297 F1 · security: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.57 to $11.09, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| September 24, 2018 Filed Sep 27, 2018 00:52 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | SaleOrdinary Shares | 529,791 | $10.04 | $5,319,154.62 |
DisclosureSEC source: 0001209191-18-052388 · doc4.xml · nonDerivative · entry 8 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 490,747 F1 · security: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.55 to $10.54, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| September 24, 2018 Filed Sep 27, 2018 00:52 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionOrdinary Shares | 100,000 | $8.77 | $877,000.00 |
DisclosureSEC source: 0001209191-18-052388 · doc4.xml · nonDerivative · entry 7 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,020,538 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| September 24, 2018 Filed Sep 27, 2018 00:52 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionOrdinary Shares | 33,750 | $8.10 | $273,375.00 |
DisclosureSEC source: 0001209191-18-052388 · doc4.xml · nonDerivative · entry 6 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 920,538 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| September 24, 2018 Filed Sep 27, 2018 00:52 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionOrdinary Shares | 52,147 | $2.95 | $153,833.65 |
DisclosureSEC source: 0001209191-18-052388 · doc4.xml · nonDerivative · entry 5 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 886,788 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| September 24, 2018 Filed Sep 27, 2018 00:52 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionOrdinary Shares | 142,500 | $2.50 | $356,250.00 |
DisclosureSEC source: 0001209191-18-052388 · doc4.xml · nonDerivative · entry 4 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 834,641 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| September 24, 2018 Filed Sep 27, 2018 00:52 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionOrdinary Shares | 112,500 | $2.50 | $281,250.00 |
DisclosureSEC source: 0001209191-18-052388 · doc4.xml · nonDerivative · entry 3 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 692,141 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| September 24, 2018 Filed Sep 27, 2018 00:52 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionOrdinary Shares | 158,334 | $2.50 | $395,835.00 |
DisclosureSEC source: 0001209191-18-052388 · doc4.xml · nonDerivative · entry 2 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 579,641 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| September 24, 2018 Filed Sep 27, 2018 00:52 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionOrdinary Shares | 20,834 | $1.40 | $29,167.60 |
DisclosureSEC source: 0001209191-18-052388 · doc4.xml · nonDerivative · entry 1 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 421,307 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| September 22, 2018 Filed Sep 25, 2018 22:36 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | GrantOrdinary Shares | 199,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-052202 · doc4.xml · nonDerivative · entry 1 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,473 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · shares: On February 2, 2015, the Reporting Person was granted 399,000 restricted stock units (the "RSUs") under the Amarin Corporation plc 2011 Stock Incentive Plan (the "Plan"). Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. The RSUs vest in two equal installments based on the Issuer's satisfaction of certain performance criteria and continued employment of the Reporting Person as provided in the Restricted Stock Unit Award Agreement between the Issuer and the Reporting Person. The performance criteria for the first installment was met, resulting in vesting of 199,500 RSUs. F3 · price: Not applicable. F4 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| June 29, 2018 Filed Jul 3, 2018 19:58 UTC | Viracta Therapeutics, Inc. SNSS · Entity 85616 | GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $2.12 | $0.00 |
DisclosureSEC source: 0001179110-18-009423 · edgar.xml · derivative · entry 1 Ketchum Steven B · CIK 0001289884 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2028-06-29 F1 · derivative.exercise_date: The option shall vest and become exercisable in twelve (12) equal monthly installments over a one (1) year period following the date of grant subject to the Reporting Person's continuous service on the Board through each such vesting date. Read SEC document |
| February 01, 2018 Filed Feb 3, 2018 01:26 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | GrantStock Option (Right to Buy) · Derivative | 117,000 | $3.80 Strike: $3.80 | $444,600.00 |
DisclosureSEC source: 0001209191-18-007273 · doc4.xml · derivative · entry 9 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,000 Underlying: Ordinary Shares · 117,000 shares Expires 2028-02-01 F10 · derivative.exercise_date: On February 1, 2018 the Reporting Person was granted an option to purchase 117,000 Ordinary Shares under the Amarin Corporation plc 2011 Stock Incentive Plan. The shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month starting on February 28, 2018. F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| February 01, 2018 Filed Feb 3, 2018 01:26 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | GrantRestricted Stock Units · Derivative | 78,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-007273 · doc4.xml · derivative · entry 8 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,000 Underlying: Ordinary Shares · 78,000 shares Expires not disclosed F7 · security: Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. F9 · derivative.exercise_date: On February 1, 2018, the Reporting Person was granted 78,000 RSUs under the Amarin Corporation plc 2011 Stock Incentive Plan. These RSUs vest in three equal installments on each of January 31, 2019, January 31, 2020 and January 31, 2021. F3 · derivative.expiration_date: Not applicable. F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| January 31, 2018 Filed Feb 3, 2018 01:26 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionRestricted Stock Units · Derivative | 29,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-007273 · doc4.xml · derivative · entry 7 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,000 Underlying: Ordinary Shares · 29,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · security: Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. F5 · derivative.exercise_date: On February 1, 2017, the Reporting Person was granted 87,000 RSUs under the Amarin Corporation plc 2011 Stock Incentive Plan. These RSUs vest in three equal installments on each of January 31, 2018, January 31, 2019 and January 31, 2020. The first vesting event occurred on January 31, 2018. F3 · derivative.expiration_date: Not applicable. F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| January 31, 2018 Filed Feb 3, 2018 01:26 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionRestricted Stock Units · Derivative | 26,667 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-007273 · doc4.xml · derivative · entry 6 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,666 Underlying: Ordinary Shares · 26,667 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · security: Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. F4 · derivative.exercise_date: On February 1, 2016, the Reporting Person was granted 80,000 RSUs under the Amarin Corporation plc 2011 Stock Incentive Plan. These RSUs vest in three equal installments on each of January 31, 2017, January 31, 2018 and January 31, 2019. The second vesting event occurred on January 31, 2018. F3 · derivative.expiration_date: Not applicable. F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| January 31, 2018 Filed Feb 3, 2018 01:26 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionRestricted Stock Units · Derivative | 60,937 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-007273 · doc4.xml · derivative · entry 5 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 60,937 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · security: Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. F2 · derivative.exercise_date: On February 2, 2015, the Reporting Person was granted 182,813 Restricted Stock Units ("RSUs") under the Amarin Corporation plc 2011 Stock Incentive Plan. These RSUs vest in three equal installments on each of January 31, 2016, January 31, 2017 and January 31, 2018. The third and final vesting event occurred on January 31, 2018. F3 · derivative.expiration_date: Not applicable. F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F8 · balance_after: Please see the section titled "Remarks" below for additional information. Read SEC document |
| January 31, 2018 Filed Feb 3, 2018 01:26 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Tax withholdingOrdinary Shares | 57,428 | $3.83 | $219,949.24 |
DisclosureSEC source: 0001209191-18-007273 · doc4.xml · nonDerivative · entry 4 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,973 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F6 · kind: Represents withholding by the Issuer of shares in respect of tax liability incident to the vesting of a security issued in accordance with Rule 16b-3, and not a market sale of securities. Read SEC document |
| January 31, 2018 Filed Feb 3, 2018 01:26 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionOrdinary Shares | 29,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-007273 · doc4.xml · nonDerivative · entry 3 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 258,401 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F5 · shares: On February 1, 2017, the Reporting Person was granted 87,000 RSUs under the Amarin Corporation plc 2011 Stock Incentive Plan. These RSUs vest in three equal installments on each of January 31, 2018, January 31, 2019 and January 31, 2020. The first vesting event occurred on January 31, 2018. F3 · price: Not applicable. Read SEC document |
| January 31, 2018 Filed Feb 3, 2018 01:26 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionOrdinary Shares | 26,667 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-007273 · doc4.xml · nonDerivative · entry 2 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 229,401 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F4 · shares: On February 1, 2016, the Reporting Person was granted 80,000 RSUs under the Amarin Corporation plc 2011 Stock Incentive Plan. These RSUs vest in three equal installments on each of January 31, 2017, January 31, 2018 and January 31, 2019. The second vesting event occurred on January 31, 2018. F3 · price: Not applicable. Read SEC document |
| January 31, 2018 Filed Feb 3, 2018 01:26 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionOrdinary Shares | 60,937 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-007273 · doc4.xml · nonDerivative · entry 1 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 202,734 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · shares: On February 2, 2015, the Reporting Person was granted 182,813 Restricted Stock Units ("RSUs") under the Amarin Corporation plc 2011 Stock Incentive Plan. These RSUs vest in three equal installments on each of January 31, 2016, January 31, 2017 and January 31, 2018. The third and final vesting event occurred on January 31, 2018. F3 · price: Not applicable. Read SEC document |
| January 23, 2018 Filed Jan 23, 2018 23:00 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionStock Option (Right to Buy) · Derivative | 135,205 | $0.00 Strike: $2.04 | $0.00 |
DisclosureSEC source: 0001209191-18-004978 · doc4.xml · derivative · entry 3 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 135,205 shares Expires 2024-01-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: On January 8, 2014, the Reporting Person was granted an option to purchase 202,500 Ordinary Shares under the Amarin Corporation plc 2011 Stock Incentive Plan. The shares subject to this option are fully vested and exercisable as of the date of this Form 4. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which represents one Ordinary Share. Read SEC document |
| January 23, 2018 Filed Jan 23, 2018 23:00 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | SaleOrdinary Shares | 135,205 | $4.41 | $596,429.82 |
DisclosureSEC source: 0001209191-18-004978 · doc4.xml · nonDerivative · entry 2 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,797 F1 · security: The exercise and sale transaction reported in the Form 4 is made pursuant to a Rule 10b5-1 plan. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which represents one Ordinary Share. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.40 to $4.45, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of Ordinary Shares sold at each separate price. F4 · balance_after: Please see the section titled "Remarks" below for additional information. Read SEC document |
| January 23, 2018 Filed Jan 23, 2018 23:00 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionOrdinary Shares | 135,205 | $2.04 | $275,818.20 |
DisclosureSEC source: 0001209191-18-004978 · doc4.xml · nonDerivative · entry 1 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 277,002 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The exercise and sale transaction reported in the Form 4 is made pursuant to a Rule 10b5-1 plan. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which represents one Ordinary Share. Read SEC document |
| January 11, 2018 Filed Jan 16, 2018 23:00 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionStock Option (right to buy) · Derivative | 2,612 | $0.00 Strike: $2.04 | $0.00 |
DisclosureSEC source: 0001209191-18-003659 · doc4.xml · derivative · entry 3 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,205 Underlying: Ordinary Shares · 2,612 shares Expires 2024-01-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: On January 8, 2014, the Reporting Person was granted an option to purchase 202,500 Ordinary Shares under the Amarin Corporation plc 2011 Stock Incentive Plan. The shares subject to this option are fully vested and exercisable as of the date of this Form 4. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which represents one Ordinary Share. Read SEC document |
| January 11, 2018 Filed Jan 16, 2018 23:00 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | SaleOrdinary Shares | 2,612 | $4.40 | $11,492.80 |
DisclosureSEC source: 0001209191-18-003659 · doc4.xml · nonDerivative · entry 2 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,797 F1 · security: The exercise and sale transaction reported in the Form 4 is made pursuant to a Rule 10b5-1 plan. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which represents one Ordinary Share. F3 · balance_after: Please see the section titled "Remarks" below for additional information. Read SEC document |
| January 11, 2018 Filed Jan 16, 2018 23:00 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionOrdinary Shares | 2,612 | $2.04 | $5,328.48 |
DisclosureSEC source: 0001209191-18-003659 · doc4.xml · nonDerivative · entry 1 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,409 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The exercise and sale transaction reported in the Form 4 is made pursuant to a Rule 10b5-1 plan. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which represents one Ordinary Share. Read SEC document |
| January 05, 2018 Filed Jan 9, 2018 23:00 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionStock Option (right to buy) · Derivative | 64,683 | $0.00 Strike: $2.04 | $0.00 |
DisclosureSEC source: 0001209191-18-003008 · doc4.xml · derivative · entry 3 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,817 Underlying: Ordinary Shares · 64,683 shares Expires 2024-01-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: On January 8, 2014, the Reporting Person was granted an option to purchase 202,500 Ordinary Shares under the Amarin Corporation plc 2011 Stock Incentive Plan. The shares subject to this option are fully vested and exercisable as of the date of this Form 4. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which represents one Ordinary Share. Read SEC document |
| January 05, 2018 Filed Jan 9, 2018 23:00 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | SaleOrdinary Shares | 64,683 | $4.40 | $284,631.07 |
DisclosureSEC source: 0001209191-18-003008 · doc4.xml · nonDerivative · entry 2 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,797 F1 · security: The exercise and sale transaction reported in the Form 4 is made pursuant to a Rule 10b5-1 plan. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which represents one Ordinary Share. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.40 to $4.41, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of Ordinary Shares sold at each separate price. F4 · balance_after: Please see the section titled "Remarks" below for additional information. Read SEC document |
| January 05, 2018 Filed Jan 9, 2018 23:00 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionOrdinary Shares | 64,683 | $2.04 | $131,953.32 |
DisclosureSEC source: 0001209191-18-003008 · doc4.xml · nonDerivative · entry 1 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 206,480 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The exercise and sale transaction reported in the Form 4 is made pursuant to a Rule 10b5-1 plan. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which represents one Ordinary Share. Read SEC document |
| January 02, 2018 Filed Jan 5, 2018 00:40 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionStock Option (Right to Buy) · Derivative | 59,896 | $0.00 Strike: $1.40 | $0.00 |
DisclosureSEC source: 0001209191-18-002255 · doc4.xml · derivative · entry 5 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,104 Underlying: Ordinary Shares · 59,896 shares Expires 2026-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: On February 1, 2016, the Reporting Person was granted an option to purchase 125,000 Ordinary Shares under the Amarin Corporation plc 2011 Stock Incentive Plan. The shares subject to this option vests in 48 equal monthly installments on the last day of each month which started on February 28, 2016. F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which represents one Ordinary Share. Read SEC document |
| January 02, 2018 Filed Jan 5, 2018 00:40 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionStock Option (Right to Buy) · Derivative | 68,361 | $0.00 Strike: $1.02 | $0.00 |
DisclosureSEC source: 0001209191-18-002255 · doc4.xml · derivative · entry 4 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,389 Underlying: Ordinary Shares · 68,361 shares Expires 2025-02-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: On February 2, 2015, the Reporting Person was granted an option to purchase 93,750 Ordinary Shares under the Amarin Corporation plc 2011 Stock Incentive Plan. The shares subject to this option vests in 48 equal monthly installments on the last day of each month which started on February 28, 2015. F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which represents one Ordinary Share. Read SEC document |
| January 02, 2018 Filed Jan 5, 2018 00:40 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | SaleOrdinary Shares | 128,257 | $4.25 | $545,092.25 |
DisclosureSEC source: 0001209191-18-002255 · doc4.xml · nonDerivative · entry 3 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,797 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which represents one Ordinary Share. F2 · kind: Sales made pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.25 to $4.255, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of Ordinary Shares sold at each separate price. F4 · balance_after: Please see the section titled "Remarks" below for additional information. Read SEC document |
| January 02, 2018 Filed Jan 5, 2018 00:40 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionOrdinary Shares | 59,896 | $1.40 | $83,854.40 |
DisclosureSEC source: 0001209191-18-002255 · doc4.xml · nonDerivative · entry 2 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 270,054 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which represents one Ordinary Share. Read SEC document |
| January 02, 2018 Filed Jan 5, 2018 00:40 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionOrdinary Shares | 68,361 | $1.02 | $69,728.22 |
DisclosureSEC source: 0001209191-18-002255 · doc4.xml · nonDerivative · entry 1 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210,158 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which represents one Ordinary Share. Read SEC document |
| October 05, 2017 Filed Oct 6, 2017 23:22 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | SaleOrdinary Shares | 63,479 | $3.48 | $221,198.92 |
DisclosureSEC source: 0001209191-17-056347 · doc4.xml · nonDerivative · entry 1 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,797 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which represents one Ordinary Share. F2 · kind: Sales made pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.46 to $3.55, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of Ordinary Shares sold at each separate price. F4 · balance_after: Please see the section titled "Remarks" below for additional information. Read SEC document |
| May 31, 2017 Filed Jun 2, 2017 17:40 UTC | Viracta Therapeutics, Inc. SNSS · Entity 85616 | GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $2.96 | $0.00 |
DisclosureSEC source: 0001179110-17-008460 · edgar.xml · derivative · entry 1 Ketchum Steven B · CIK 0001289884 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2027-05-31 F1 · derivative.exercise_date: The option vests over one (1) year in equal monthly installments from the date of grant. Read SEC document |
| May 15, 2017 Filed Jul 3, 2017 23:21 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | GrantRestricted Stock Units · Derivative | 87,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-042902 · doc4.xml · derivative · entry 1 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,000 Underlying: Ordinary Shares · 87,000 shares Expires not disclosed F1 · security: Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. F2 · derivative.exercise_date: On February 1, 2017, the Reporting Person was granted 87,000 restricted stock units (the "RSUs") under the Amarin Corporation plc 2011 Stock Incentive Plan (the "Plan"). These RSUs were subject to the approval by the Company's shareholders of an amendment to the Plan, which amendment was approved on May 15, 2017, and were previously disclosed in the Company's definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on April 21, 2017. These RSUs vest in three equal installments on each of January 31, 2018, January 31, 2019 and January 31, 2020. F3 · derivative.expiration_date: Not Applicable. F4 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| February 01, 2017 Filed Feb 2, 2017 22:06 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | GrantStock Option (right to buy) · Derivative | 133,000 | $2.95 Strike: $2.95 | $392,350.00 |
DisclosureSEC source: 0001209191-17-007167 · doc4.xml · derivative · entry 8 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,000 Underlying: Ordinary Shares · 133,000 shares Expires 2027-01-31 F8 · derivative.exercise_date: On February 1, 2017, the Reporting Person was granted an option to purchase 133,000 Ordinary Shares under the Amarin Corporation plc 2011 Stock Incentive Plan. The shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month starting on February 28, 2017. F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| January 31, 2017 Filed Feb 2, 2017 22:06 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionRestricted Stock Units · Derivative | 26,667 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-007167 · doc4.xml · derivative · entry 7 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,333 Underlying: Ordinary Shares · 26,667 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · security: Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. F5 · derivative.exercise_date: On February 1, 2016, the Reporting Person was granted 80,000 RSUs under the Amarin Corporation plc 2011 Stock Incentive Plan. These RSUs vest in three equal installments on each of January 31, 2017, January 31, 2018 and January 31, 2019. The first vesting event occurred on January 31, 2017. F3 · derivative.expiration_date: Not applicable. F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| January 31, 2017 Filed Feb 2, 2017 22:06 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionRestricted Stock Units · Derivative | 60,938 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-007167 · doc4.xml · derivative · entry 6 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,937 Underlying: Ordinary Shares · 60,938 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · security: Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. F4 · derivative.exercise_date: On February 2, 2015, the Reporting Person was granted 182,813 RSUs under the Amarin Corporation plc 2011 Stock Incentive Plan. These RSUs vest in three equal installments on each of January 31, 2016, January 31, 2017 and January 31, 2018. The second vesting event occurred on January 31, 2017. F3 · derivative.expiration_date: Not applicable. F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| January 31, 2017 Filed Feb 2, 2017 22:06 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionRestricted Stock Units · Derivative | 56,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-007167 · doc4.xml · derivative · entry 5 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 56,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · security: Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. F2 · derivative.exercise_date: On January 8, 2014, the Reporting Person was granted 169,500 restricted stock units ("RSUs") under the Amarin Corporation plc 2011 Stock Incentive Plan. These RSUs vest in three equal installments on each of January 31, 2015, January 31, 2016 and January 31, 2017. The third and final vesting event occurred on January 31, 2017. F3 · derivative.expiration_date: Not applicable. F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.